Finally, IDHmt glioma cells have been shown to specifically exhibit greater levels of Notch ligand delta-like 3 (DLL3) RNA and were sensitive to anti-DLL3 antibodies [115]. This evidence concerns the gene DLL3 and central nervous system cancer.